The Latin America, Middle East and Africa Antimicrobial Resistance Diagnostics Market would witness market growth of 11.9% CAGR during the forecast period (2022-2028).
The development of new antimicrobials, better management of sick patients, and greater antimicrobial stewardship are all made possible by rapid and thorough diagnostics, which are essential for managing antimicrobial resistance. Certain illnesses, such as ventilator-associated pneumonia and sepsis, might increase mortality if proper antibiotic therapy is delayed. The early start of targeted narrow-spectrum therapies with proven antimicrobial activities against the infection's causative factor will be made possible by the rapid determination of pathogenic organisms and antimicrobial resistance, which will alter how clinicians manage infection.
Rapid diagnostics are ultimately aiming to identify the pathogen and its antimicrobial susceptibility using clinical samples at the point of care in less than 30 minutes. Presently, providing a thorough microbiological diagnosis prior to the second dosage of empirical treatment is considered to be adequate to enhance patient outcomes and stewardship.
The primary drivers of the market expansion are the high illness burden caused by pathogens including streptococcus pneumonia, C. difficile infections, MRSA, and others along with the sharp increase in the prevalence of infections caused by AMR. Additionally, increased regulatory approvals of medical diagnostics and the rising need for technologically sophisticated diagnostic tools to manage AMR are also projected to promote the growth of the market. Antimicrobial resistance's growing danger is anticipated to help the industry grow. Global governments are working to raise the standard of diagnostics for accurate point-of-care diagnosis.
In the UAE, the national action plan (NAP) on AMR was created to outline the current plans for national responses to AMR in the fields of food safety, environmental protection, and human and animal health. Technical subcommittees took the lead in developing and implementing strategies and activities in particular fields, like antimicrobial stewardship programs (ASP), surveillance, AMR prevention and control, and infection prevention and control (IPC). Together with other relevant ministries, authorities, organizations, research institutes, comparison laboratories, and other institutions, these activities will be carried out. As a consequence, AMR testing is gaining momentum in the region and is driving the growth of the antimicrobial resistance diagnostics market.
The Brazil market dominated the LAMEA Antimicrobial Resistance Diagnostics Market by Country in 2021; thereby, achieving a market value of $131.7 million by 2028. The Argentina market is showcasing a CAGR of 12.5% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 11.6% during (2022 - 2028).
Based on Technology, the market is segmented into PCR, Immunoassay, NGS, Microbiology Culture, Mass Spectrometry, Rapid & Point of Care and Others. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Pharmaceutical, Biotechnology Companies & Others. Based on Pathogen, the market is segmented into Methicillin Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile (CD), Drug Resistant Campylobacter (DRC), Drug Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRNTS) and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Antimicrobial Resistance Diagnostics Market is Predict to reach $5.7 Billion by 2028, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Danaher Corporation, Accelerate Diagnostics, Inc., Hologic, Inc., Visby Medical, Inc., Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd) and Molsid S.A.S.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- PCR
- Immunoassay
- NGS
- Microbiology Culture
- Mass Spectrometry
- Rapid & Point of Care
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical, Biotechnology Companies & Others
By Pathogen
- Methicillin Resistant Staphylococcus Aureus (MRSA)
- Clostridium Difficile (CD)
- Drug Resistant Campylobacter (DRC)
- Drug Resistant Streptococcus Pneumoniae (DRSP)
- Drug Resistant Neisseria Gonorrhoeae (DRNG)
- Drug Resistant Salmonella (DRNTS)
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- BioMérieux S.A.
- F.Hoffmann-La Roche Ltd.
- Becton, Dickinson and Company
- Danaher Corporation
- Accelerate Diagnostics, Inc.
- Hologic, Inc.
- Visby Medical, Inc.
- Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
- Molsid S.A.S.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Antimicrobial Resistance Diagnostics Market, by Technology
1.4.2 LAMEA Antimicrobial Resistance Diagnostics Market, by End User
1.4.3 LAMEA Antimicrobial Resistance Diagnostics Market, by Pathogen
1.4.4 LAMEA Antimicrobial Resistance Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. LAMEA Antimicrobial Resistance Diagnostics Market by Technology
4.1 LAMEA PCR Market by Country
4.2 LAMEA Immunoassay Market by Country
4.3 LAMEA NGS Market by Country
4.4 LAMEA Microbiology Culture Market by Country
4.5 LAMEA Mass Spectrometry Market by Country
4.6 LAMEA Rapid & Point of Care Market by Country
4.7 LAMEA Others Market by Country
Chapter 5. LAMEA Antimicrobial Resistance Diagnostics Market by End-user
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Diagnostic Laboratories Market by Country
5.3 LAMEA Pharmaceutical, Biotechnology Companies & Others Market by Country
Chapter 6. LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen
6.1 LAMEA Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
6.2 LAMEA Clostridium Difficile (CD) Market by Country
6.3 LAMEA Drug Resistant Campylobacter (DRC) Market by Country
6.4 LAMEA Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
6.5 LAMEA Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
6.6 LAMEA Drug Resistant Salmonella (DRNTS) Market by Country
6.7 LAMEA Others Market by Country
Chapter 7. LAMEA Antimicrobial Resistance Diagnostics Market by Country
7.1 Brazil Antimicrobial Resistance Diagnostics Market
7.1.1 Brazil Antimicrobial Resistance Diagnostics Market by Technology
7.1.2 Brazil Antimicrobial Resistance Diagnostics Market by End-user
7.1.3 Brazil Antimicrobial Resistance Diagnostics Market by Pathogen
7.2 Argentina Antimicrobial Resistance Diagnostics Market
7.2.1 Argentina Antimicrobial Resistance Diagnostics Market by Technology
7.2.2 Argentina Antimicrobial Resistance Diagnostics Market by End-user
7.2.3 Argentina Antimicrobial Resistance Diagnostics Market by Pathogen
7.3 UAE Antimicrobial Resistance Diagnostics Market
7.3.1 UAE Antimicrobial Resistance Diagnostics Market by Technology
7.3.2 UAE Antimicrobial Resistance Diagnostics Market by End-user
7.3.3 UAE Antimicrobial Resistance Diagnostics Market by Pathogen
7.4 Saudi Arabia Antimicrobial Resistance Diagnostics Market
7.4.1 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Technology
7.4.2 Saudi Arabia Antimicrobial Resistance Diagnostics Market by End-user
7.4.3 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Pathogen
7.5 South Africa Antimicrobial Resistance Diagnostics Market
7.5.1 South Africa Antimicrobial Resistance Diagnostics Market by Technology
7.5.2 South Africa Antimicrobial Resistance Diagnostics Market by End-user
7.5.3 South Africa Antimicrobial Resistance Diagnostics Market by Pathogen
7.6 Nigeria Antimicrobial Resistance Diagnostics Market
7.6.1 Nigeria Antimicrobial Resistance Diagnostics Market by Technology
7.6.2 Nigeria Antimicrobial Resistance Diagnostics Market by End-user
7.6.3 Nigeria Antimicrobial Resistance Diagnostics Market by Pathogen
7.7 Rest of LAMEA Antimicrobial Resistance Diagnostics Market
7.7.1 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Technology
7.7.2 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by End-user
7.7.3 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 BioMérieux S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition, Joint Ventures and Mergers:
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Danaher Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Hologic, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Financial Analysis
8.6.4 Segmental and Regional Analysis
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.7 Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Molsid SAS
8.8.1 Company Overview
8.9 Visby Medical, Inc.
8.9.1 Company Overview
8.10. Accelerated Technology Laboratories, Inc.
8.10.1 Company Overview
TABLE 1 LAMEA Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antimicrobial Resistance Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Antimicrobial Resistance Diagnostics Market
TABLE 5 Acquisition and Mergers– Antimicrobial Resistance Diagnostics Market
TABLE 6 LAMEA Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 7 LAMEA Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 8 LAMEA PCR Market by Country, 2018 - 2021, USD Million
TABLE 9 LAMEA PCR Market by Country, 2022 - 2028, USD Million
TABLE 10 LAMEA Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 11 LAMEA Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 12 LAMEA NGS Market by Country, 2018 - 2021, USD Million
TABLE 13 LAMEA NGS Market by Country, 2022 - 2028, USD Million
TABLE 14 LAMEA Microbiology Culture Market by Country, 2018 - 2021, USD Million
TABLE 15 LAMEA Microbiology Culture Market by Country, 2022 - 2028, USD Million
TABLE 16 LAMEA Mass Spectrometry Market by Country, 2018 - 2021, USD Million
TABLE 17 LAMEA Mass Spectrometry Market by Country, 2022 - 2028, USD Million
TABLE 18 LAMEA Rapid & Point of Care Market by Country, 2018 - 2021, USD Million
TABLE 19 LAMEA Rapid & Point of Care Market by Country, 2022 - 2028, USD Million
TABLE 20 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 21 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 22 LAMEA Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 23 LAMEA Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 24 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 25 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 26 LAMEA Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 27 LAMEA Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 28 LAMEA Pharmaceutical, Biotechnology Companies & Others Market by Country, 2018 - 2021, USD Million
TABLE 29 LAMEA Pharmaceutical, Biotechnology Companies & Others Market by Country, 2022 - 2028, USD Million
TABLE 30 LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 31 LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 32 LAMEA Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2018 - 2021, USD Million
TABLE 33 LAMEA Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2022 - 2028, USD Million
TABLE 34 LAMEA Clostridium Difficile (CD) Market by Country, 2018 - 2021, USD Million
TABLE 35 LAMEA Clostridium Difficile (CD) Market by Country, 2022 - 2028, USD Million
TABLE 36 LAMEA Drug Resistant Campylobacter (DRC) Market by Country, 2018 - 2021, USD Million
TABLE 37 LAMEA Drug Resistant Campylobacter (DRC) Market by Country, 2022 - 2028, USD Million
TABLE 38 LAMEA Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2018 - 2021, USD Million
TABLE 39 LAMEA Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2022 - 2028, USD Million
TABLE 40 LAMEA Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2018 - 2021, USD Million
TABLE 41 LAMEA Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2022 - 2028, USD Million
TABLE 42 LAMEA Drug Resistant Salmonella (DRNTS) Market by Country, 2018 - 2021, USD Million
TABLE 43 LAMEA Drug Resistant Salmonella (DRNTS) Market by Country, 2022 - 2028, USD Million
TABLE 44 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 45 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 46 LAMEA Antimicrobial Resistance Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 47 LAMEA Antimicrobial Resistance Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 48 Brazil Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 49 Brazil Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 50 Brazil Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 51 Brazil Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 52 Brazil Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 53 Brazil Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 54 Brazil Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 55 Brazil Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 56 Argentina Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 57 Argentina Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 58 Argentina Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 59 Argentina Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 60 Argentina Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 61 Argentina Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 62 Argentina Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 63 Argentina Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 64 UAE Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 65 UAE Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 66 UAE Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 67 UAE Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 68 UAE Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 69 UAE Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 70 UAE Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 71 UAE Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 72 Saudi Arabia Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 73 Saudi Arabia Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 74 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 75 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 76 Saudi Arabia Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 77 Saudi Arabia Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 78 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 79 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 80 South Africa Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 81 South Africa Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 82 South Africa Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 83 South Africa Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 84 South Africa Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 85 South Africa Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 86 South Africa Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 87 South Africa Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 88 Nigeria Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 89 Nigeria Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 90 Nigeria Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 91 Nigeria Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 92 Nigeria Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 93 Nigeria Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 94 Nigeria Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 95 Nigeria Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 96 Rest of LAMEA Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 97 Rest of LAMEA Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 98 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 99 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 100 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 101 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 102 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 103 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 104 Key Information – Abbott Laboratories
TABLE 105 Key information – Becton, Dickinson and Company
TABLE 106 Key information – BioMérieux S.A.
TABLE 107 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 108 Key Information – Danaher Corporation
TABLE 109 Key information – Hologic, Inc.
TABLE 110 Key Information – Vela Diagnostics Pte. Ltd.
TABLE 111 Key Information – Molsid SAS
TABLE 112 Key Information – Visby Medical, Inc.
TABLE 113 key information – Accelerated Technology Laboratories, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Swot analysis: Abbott laboratories
FIG 5 Recent strategies and developments: BioMérieux S.A.
FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.